2006 FDA Governance Licensing 
SQA
JUNE 10, 2021
The new regulation, RDC 478/2021 , repeals economic monitoring and reporting processes previously established under RDC 185/2006, and initially reduces the number of medical device types for which economic monitoring will be required. The Government of Canada’s number one priority is to protect the health of Canadians.
Drug & Device Law
FEBRUARY 20, 2023
But in prescription medical product liability litigation, products must receive FDA approval, clearance or other authorization (hereafter, collectively referred to as “approval” for short) before they can be marketed. Are manufacturers liable only for failing to employ an alternative design that the FDA has approved for distribution. . .
Expert insights. Personalized for you.
52 
Let's personalize your content